{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:18:41Z","timestamp":1787023121248,"version":"build-2736575974"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Alcoholic liver disease (ALD) and metabolic-dysfunction associated steatotic liver disease (MASLD) are common, and gut microbiota (GM) is involved with both. Here we compared GM composition in animal models of MASLD and ALD to assess whether there are specific patterns for each disease.  Methods: MASLD model- adult male Sprague Dawley rats, randomized into two groups: MASLD-control (n=10) fed a standard diet; MASLD-group (n=10) fed a high-fat-choline-deficient diet for 16 weeks. ALD model- adult male Wistar rats randomized: ALD-control (n=8) fed a standard diet and water+0.05% saccharin, ALD groups fed with sunflower seed and 10% ethanol+0.05% saccharin for 4 or 8 weeks (ALC4, n=8; ALC8, n=8). ALC4\/8 on the last day received alcoholic binge (5g\/kg of ethanol). Afterwards, animals were euthanized, and feces were collected for GM analysis.  Results: Both experimental models induced typical histopathological features of the diseases. Alpha diversity was lower in MASLD compared with ALD (p&lt;0.001), and structural pattern was different between them (P&lt;0.001). Bacteroidetes (55.7%), Firmicutes (40.6%), and Proteobacteria (1.4%) were the most prevalent phyla in all samples, although differentially abundant among groups. ALC8 had a greater abundance of the phyla Cyanobacteria (5.3%) and Verrucomicrobiota (3.2%) in relation to the others. Differential abundance analysis identified Lactobacillaceae_unclassified, Lachnospiraceae_NK4A136_group, and Turicibacter associated with ALC4 and the Clostridia_UCG_014_ge and Gastranaerophilales_ge genera to ALC8.  Conclusion: In this study, we demonstrated that the structural pattern of the GM differs significantly between MASLD and ALD models. Studies are needed to characterize the microbiota and metabolome in both clinical conditions to find new therapeutic strategies.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612023-100","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:10:53Z","timestamp":1710511853000},"source":"Crossref","is-referenced-by-count":4,"title":["COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS"],"prefix":"10.1590","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2651-7588","authenticated-orcid":false,"given":"C\u00e1ssio Marques","family":"PERLIN","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4453-7227","authenticated-orcid":false,"given":"Larisse","family":"LONGO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-0366","authenticated-orcid":false,"given":"Rutiane Ullmann","family":"THOEN","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0526-3067","authenticated-orcid":false,"given":"Carolina","family":"URIBE-CRUZ","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Cat\u00f3lica de las Misiones,  Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-246X","authenticated-orcid":false,"given":"M\u00e1rio Reis","family":"\u00c1LVARES-DA-SILVA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"111235","DOI":"10.1016\/j.biopha.2021.111235","article-title":"The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD","volume":"135","author":"Huang W","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang H","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang R","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clnesp.2021.05.012","article-title":"Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms","volume":"44","author":"Bakhshimoghaddam F","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","article-title":"Role of gut microbiota in liver disease","volume":"318","author":"Albhaisi SAM","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4254\/wjh.v13.i12.2052","article-title":"Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis","volume":"13","author":"Longo L","year":"2021","journal-title":"World J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature","volume":"20","author":"Milosevic I","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/ijms23010426","article-title":"Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases","volume":"23","author":"Park JW","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CEG.S262879","article-title":"Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats","volume":"13","author":"Longo L","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"111888","DOI":"10.1016\/j.nut.2022.111888","article-title":"Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters","volume":"106","author":"Thoen RU","year":"2022","journal-title":"Nutrition"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang W","year":"2014","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner DE","year":"2005","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss PD","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2584","article-title":"VSEARCH: a versatile open source tool for metagenomics","volume":"4","author":"Rognes T","year":"2016","journal-title":"PeerJ"},{"issue":"Database issue","key":"ref16","first-page":"D590","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast C","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future","volume":"28","author":"Lang S","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fmed.2020.00448","article-title":"Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities","volume":"7","author":"Idalsoaga F","year":"2020","journal-title":"Front Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgh3.12097","article-title":"Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease","volume":"3","author":"Yamamoto K","year":"2019","journal-title":"JGH Open"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes C","year":"2018","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/microorganisms3040759","article-title":"Gut Microbiota and Host Reaction in Liver Diseases","volume":"3","author":"Fukui H","year":"2015","journal-title":"Microorganisms"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj JS","year":"2018","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications","volume":"21","author":"Chen J","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives","volume":"12","author":"Vallianou N","year":"2021","journal-title":"Biomolecules"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier J","year":"2016","journal-title":"Hepatology"},{"key":"ref26","article-title":"CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients","volume":"101","author":"Ge H","year":"2022","journal-title":"Medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3390\/foods11172703","article-title":"Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease","volume":"11","author":"Jeong MK","year":"2022","journal-title":"Foods"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/pr400263n","article-title":"Gut microbiota composition modifies fecal metabolic profiles in mice","author":"Zhao Y","year":"2013","journal-title":"J Proteome Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1016\/j.csbj.2021.10.032","article-title":"Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease","volume":"19","author":"Si J","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00047-22","article-title":"Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice","volume":"10","author":"Zhuge A","year":"2022","journal-title":"Microbiol Spectr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"870785","DOI":"10.3389\/fcimb.2022.870785","article-title":"The Microbiota and It\u2019s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease","volume":"12","author":"Gu C","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1888673","article-title":"Links between gut microbiome composition and fatty liver disease in a large population sample","volume":"13","author":"Ruuskanen MO","year":"2021","journal-title":"Gut Microbes"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","article-title":"Alcoholic liver disease: Utility of animal models","volume":"24","author":"Lamas-Paz A","year":"2018","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.1840100417","article-title":"Experimental methods of ethanol administration","volume":"10","author":"Lieber CS","year":"1989","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-242-7_3","article-title":"Intragastric ethanol infusion model in rodents","volume":"447","author":"Tsukamoto H","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"128773","DOI":"10.1016\/j.chemosphere.2020.128773","article-title":"Sub-chronic microcystin-LR renal toxicity in rats fed a high fat\/high cholesterol diet","volume":"269","author":"Arman T","year":"2021","journal-title":"Chemosphere"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan AW","year":"2011","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/19490976.2020.1736457","article-title":"Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model","volume":"11","author":"Yu L","year":"2020","journal-title":"Gut Microbes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis","volume":"24","author":"Ye JZ","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0007-2016","article-title":"Microbiota, Liver Diseases, and Alcohol","volume":"5","author":"Cassard AM","year":"2017","journal-title":"Microbiol Spectr"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Compara\u00e7\u00e3o da microbiota intestinal em modelos animais de doen\u00e7a hep\u00e1tica esteat\u00f3tica alco\u00f3lica e metab\u00f3lica"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032024000100500&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:11:08Z","timestamp":1710511868000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032024000100500&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":40,"alternative-id":["S0004-28032024000100500"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612023-100","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e23100"}}